TECHLAB® designs, develops, and manufactures enteric diagnostics that are distributed worldwide. We have ISO 13485 certification and MDSAP, and FDA registration.
Innovations in the Diagnosis of Intestinal Diseases
Our research focuses on enteric disease and microbiology of the intestinal tract, and our scope of study includes:
- Markers of intestinal inflammation
- The toxins of Clostridioides difficile (formerly Clostridium), STEC, and C. perfringens
- Intestinal pathogens
- Vaccine development
- C. difficile
- Intestinal inflammation
- Shiga toxins
- Respiratory pathogens
The founders of TECHLAB met in the late 1970s at Virginia Tech’s Anaerobe Laboratory, where they were investigating diagnosis and treatments for Clostridioides difficile (formerly Clostridium) infection. Led by Dr. Tracy Wilkins, the researchers developed the first commercial diagnostic reagents for C. difficile disease.
Demand for the antiserum grew quickly when it was discovered that C. difficile is a major hospital pathogen, and TECHLAB was incorporated in 1989 to produce and distribute the product.
TECHLAB® research and development is located at the Corporate Research Center in Blacksburg, VA.
TECHLAB® manufacturing is located in Radford, VA.